Close Menu

NEW YORK – BC Platforms said Wednesday that it has closed a $15 million Series C financing round and entered into a strategic partnership with healthcare analytics powerhouse IQvia.  Durham, North Carolina-based IQvia led the investment round, with participation from Debiopharm Innovation Fund and Finnish investment firm Tesi.

In their partnership, BC Platforms and IQvia will develop "data-driven technologies" to integrate genomic and clinical data to support biomedical research, the companies said. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.